Skip to main content
. 2010 Nov 24;2010:0710.
Ref (type) Population Outcome, Interventions Results and statistical analysis Effect size Favours
Cataracts

RCT
416 people, 416 eyes with phakic rhegmatogenous retinal detachment (RRD)
Subgroup analysis
Development or progression of cataracts
96/209 (46%) with scleral buckling
160/207 (77%) with pars plana vitrectomy with infusion of short-acting gas

Treatment difference 31.4%
95% CI 22.5% to 40.2%
P <0.0001
Results should be interpreted with caution (see further information on studies for full details)
Effect size not calculated scleral buckling

RCT
416 people, 416 eyes with phakic RRD
Subgroup analysis
Surgery to remove cataracts
43/209 (21%) with scleral buckling
120/207 (58%) with pars plana vitrectomy with infusion of short-acting gas

Treatment difference 37.4%
95% CI 28.7% to 46.1%
Results should be interpreted with caution (see further information on studies for full details)
Effect size not calculated scleral buckling

RCT
61 people, 61 eyes, with phakic RRD without proliferative vitreoretinopathy (PVR) of grade C or above. Development of cataract
0/31 (0%) with scleral buckling
5/30 (17%) with pars plana vitrectomy with infusion of long-acting gas plus 360 laser to peripheral retina

P = 0.018
Effect size not calculated scleral buckling
Proliferative vitreoretinopathy

RCT
416 people, 416 eyes with phakic RRD
Subgroup analysis
PVR
26/209 (12%) with scleral buckling
34/207 (16%) with pars plana vitrectomy with infusion of short-acting gas

P = 0.2812
Results should be interpreted with caution (see further information on studies for full details)
Not significant

RCT
46 people aged 50 years and older, 46 eyes with phakic RRD involving the macula with recent posterior vitreous detachment and equatorial tears PVR
1/23 (4%) with scleral buckling
2/23 (9%) with pars plana vitrectomy with infusion of short-acting gas combined with phacoemulsification surgery

Significance not assessed
Intraocular pressure

RCT
46 people aged 50 years and older, 46 eyes with phakic RRD involving the macula with recent posterior vitreous detachment and equatorial tears Elevation of intraocular pressure (>30 mmHg)
3/23 (13%) with scleral buckling
4/23 (17%) with pars plana vitrectomy with infusion of short-acting gas combined with phacoemulsification surgery

Significance not assessed

RCT
61 people, 61 eyes, with phakic RRD without PVR of grade C or above Elevated of intraocular pressure
2/31 (6.5%) with scleral buckling
2/30 (6.7%) with pars plana vitrectomy with infusion of long-acting gas plus 360 laser to peripheral retina

Significance not assessed
Other adverse effects

RCT
416 people, 416 eyes with phakic RRD
Subgroup analysis
Retinal re-detachment 1 year
55/209 (26%) with scleral buckling
52/207 (25%) with pars plana vitrectomy with infusion of short-acting gas

Significance not assessed
Results should be interpreted with caution (see further information on studies for full details)

RCT
46 people aged 50 years and older, 46 eyes with phakic RRD involving the macula with recent posterior vitreous detachment and equatorial tears Macular pucker
4/23 (17%) with scleral buckling
0/23 (0%) with pars plana vitrectomy with infusion of short-acting gas combined with phacoemulsification surgery

Significance not assessed

RCT
61 people, 61 eyes, with phakic RRD without PVR of grade C or above Epiretinal membrane
1/31 (3.2%) with scleral buckling
1/30 (3.3%) with pars plana vitrectomy with infusion of long-acting gas plus 360 laser to peripheral retina

Significance not assessed